Sign in Subscribe
Securities law

Molina Healthcare Sued for Potential Securities Law Violations

Strategic Insights

— 2 min read

A securities law firm has filed a lawsuit against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws. The complaint alleges that the company made false statements about its earnings growth and ability to mitigate medical costs, leading to a significant decline in stock price. Investors who purchased Molina securities may be eligible to participate in the lawsuit.

Key Takeaways:

  • The lawsuit was filed by Bleichmar Fonti & Auld LLP, a leading securities law firm, on behalf of investors in Molina Healthcare, Inc. (NYSE: MOH) securities.
  • The complaint alleges that Molina made false statements about its earnings growth and ability to mitigate medical costs, including stating that the company's "earnings growth profile" was "solid heading into 2025."
  • The company revealed that its Q2 2025 adjusted earnings were below expectations due to "medical cost pressures in all three lines of business," leading to a 16.8% decline in stock price.
  • The lawsuit seeks to recover losses on behalf of investors who purchased Molina securities between May 3, 2022, and July 24, 2025.
  • The case is pending in the U.S. District Court for the Central District of California, captioned Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461.
  • Molina stated that it will "continuously monitor utilization patterns" and "mitigate the negative effects of healthcare cost inflation," but the company faced increased medical costs pressures it could not mitigate.
  • The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
  • Investors have until December 2, 2025, to ask the Court to be appointed to lead the case.
  • If you invested in Molina before July 24, 2025, you are encouraged to obtain more information by visiting: .

Statistics:

  • Molina stock price declined by $32.03 per share, or 16.8%, from $190.25 per share on July 23, 2025, to $158.22 per share on July 24, 2025.
  • The company revealed that it expected its full year 2025 adjusted earnings to be no less than $19.00 per diluted share on July 23, 2025, indicating a significant decline from its prior expectations.
  • The lawsuit seeks to recover losses on behalf of investors who purchased Molina securities between May 3, 2022, and July 24, 2025.

Sources:

  • Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 (U.S. District Court for the Central District of California).
  • Globe Newswire, "Molina Healthcare, Inc. Investor Alert: Lawsuit Filed for Shareholders with Losses Exceeding $100,000 in Molina Healthcare, Inc. Following Securities Class Action Filed" (October 18, 2025).
  • Bleichmar Fonti & Auld LLP, "Molina Healthcare, Inc. Securities Class Action Lawsuit Filed" (October 18, 2025).
  • Securities and Exchange Commission, "Section 10(b) and Rule 10b-5".
  • Securities and Exchange Commission, "Section 20(a)".

Read more